Ce groupe d'étude se penche sur ces questions, notamment sur les médicaments de source isolée, puisque les régimes d'assurance- médicaments des provinces s'y intéressent, particulièrement ceux de l'Ontario et de la Colombie-Britannique, et d'autres provinces encore, tout comme ils s'intéressent aux médicaments de sources multiples.
They are looking at those issues, including single-source drugs, as they're being examined through the provincial drug plans—particularly Ontario and B.C., and other provinces are being included in those considerations—as well as multiple-source drugs.